Company intelligence / Profile preview

Flow VC

Ownership: Private
Development stage: Other

Overview

Flow VC appears to be a venture capital fund rather than a life science, biotech, pharma, or healthcare operating company. Publicly discoverable information indicates that it invests in European start-ups and supports portfolio company growth. Based on the available evidence, there is no clear indication that Flow VC itself develops therapeutics, diagnostics, medical devices, or healthcare services. As a result, standard biotech company fields such as pipeline, modalities, targets, and indications do not appear applicable. The entity seems best classified as an active private investment organization.

Industry: Investors

Beyond the preview

Go deeper on Flow VC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Flow VC.

Explore the full profile